EMD-7568
Glutaraldehyde-treated BG505 SOSIP.664 Env in complex with PGV04 Fab
EMD-7568
Single-particle4.2 Å
Deposition: 19/03/2018Map released: 18/04/2018
Last modified: 06/11/2024
Sample Organism:
Human immunodeficiency virus 1,
Homo sapiens
Sample: Glutaraldehyde-treated BG505 SOSIP.664 Env in complex with PGV04 Fab
Fitted models: 6crq
Deposition Authors: Pallesen J
,
de Val N,
Ward AB
Sample: Glutaraldehyde-treated BG505 SOSIP.664 Env in complex with PGV04 Fab
Fitted models: 6crq
Deposition Authors: Pallesen J
,
de Val N,
Ward AB
Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins.
Schiffner T ,
Pallesen J ,
Russell RA ,
Dodd J ,
de Val N,
LaBranche CC,
Montefiori D,
Tomaras GD,
Shen X,
Harris SL,
Moghaddam AE ,
Kalyuzhniy O ,
Sanders RW,
McCoy LE ,
Moore JP,
Ward AB,
Sattentau QJ
(2018) PLoS Pathog , 14 , e1006986 - e1006986
,
Pallesen J ,
Russell RA ,
Dodd J ,
de Val N,
LaBranche CC,
Montefiori D,
Tomaras GD,
Shen X,
Harris SL,
Moghaddam AE ,
Kalyuzhniy O ,
Sanders RW,
McCoy LE ,
Moore JP,
Ward AB,
Sattentau QJ
(2018) PLoS Pathog , 14 , e1006986 - e1006986
Grant Support:
- BMGF: OPP1113647 (United States)
- H2020 European AIDS Vaccine Initiative: 681137
- International AIDS Vaccine Initiative: OPP1084519 (United States)
- International AIDS Vaccine Initiative: OPP1115782 (United States)